EVH
Evolent Health, Inc.
NYSE · Healthcare · Medical - Healthcare Information Services · US
$4.30
+0.82%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 2.1B | 1.9B | 2.6B | 2.0B | 1.4B |
| Cost of Revenue | 1.8B | 1.6B | 2.2B | 1.5B | 1.0B |
| Gross Profit | 270.8M | 284.0M | 367.4M | 460.5M | 316.6M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | 27.0M |
| SG&A Expense | 277.9M | 288.5M | 263.1M | 358.1M | 269.3M |
| General & Admin Expense | 68.8M | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 21.6M | — | 144.8M | 173.6M | 16.7M |
| Total Operating Expenses | 299.5M | 288.5M | 407.8M | 531.7M | 312.9M |
| Cost and Expenses | 2.1B | 1.9B | 2.6B | 2.0B | 1.3B |
| Operating Income (EBIT) | (28.7M) | (4.4M) | (40.5M) | (71.2M) | 3.6M |
| Non-Operating | |||||
| Interest Income | 3.5M | 4.2M | 5.5M | 5.3M | 1.4M |
| Interest Expense | 69.2M | 57.5M | 24.7M | 54.2M | 15.6M |
| Net Interest Income | (65.7M) | (53.3M) | (19.2M) | (48.9M) | (14.2M) |
| Other Non-Op Income/Expense | (473.5M) | (530.2M) | (22.6M) | (131.2M) | (65.7M) |
| Non-Operating Income (excl Interest) | 404.2M | 472.7M | (2.2M) | 77.0M | 50.1M |
| EBT (Pre-Tax Income) | (502.1M) | (534.6M) | (63.0M) | (202.4M) | (62.1M) |
| Income Tax Expense | 2.9M | (126.0K) | (1.4M) | (89.4M) | (43.4M) |
| Bottom Line | |||||
| Net Income | (505.0M) | (534.5M) | (61.6M) | (113.0M) | (19.2M) |
| Earnings from Cont. Ops | (505.0M) | (534.5M) | (61.6M) | (113.0M) | (18.7M) |
| Earnings from Discont. Ops | — | — | — | — | (463.0K) |
| Bottom Line Net Income | (511.1M) | (579.4M) | (93.5M) | (142.3M) | (18.7M) |
| Per Share | |||||
| Basic EPS | ($4.49) | ($5.07) | ($0.81) | ($1.28) | ($0.20) |
| Diluted EPS | ($4.49) | ($5.07) | ($0.81) | ($1.28) | ($0.20) |
| Revenue Per Share | $18.63 | $16.43 | $22.28 | $17.65 | $14.43 |
| Shares | |||||
| Basic Shares Outstanding | 112.5M | 114.2M | 114.7M | 111.3M | 93.7M |
| Diluted Shares Outstanding | 112.5M | 114.2M | 114.7M | 111.3M | 93.7M |
| Profitability Metrics | |||||
| EBITDA | (317.0M) | (361.3M) | 84.9M | (24.8M) | 43.7M |
| D&A | 115.9M | 115.9M | 123.2M | 123.4M | 90.3M |
| EBIT | (432.9M) | (477.2M) | (38.3M) | (148.2M) | (46.5M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026